The global market for Biosuperior was estimated to be worth US$ 832 million in 2023 and is forecast to a readjusted size of US$ 1538 million by 2030 with a CAGR of 9.1% during the forecast period 2024-2030

Biosuperior - Market

Biobetters, also known as biosuperiors, are recombinant protein drugs from an identical class as a present set of biopharmaceuticals is not similar to the source. It is neither a wholly novel medicine nor a generic version of an old drug. It is a biological product designed to increase clinical efficacy while also improving tolerance and lowering dosing/administration frequency.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biosuperior, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Biosuperior by region & country, by Type, and by Application.

The Biosuperior market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosuperior.

Market Segmentation

Scope of Biosuperior - Market Report

Report Metric	Details
Report Name	Biosuperior - Market
Forecasted market size in 2030	US$ 1538 million
CAGR	9.1%
Forecasted years	2024 - 2030
Segment by Type:	G-CSF Biobetters Insulin Biobetters Erythropoietin Biobetters Monoclonal Antibodies Biobetters Others
Segment by Application	Cancer Diabetes Genetic Disease Neurological Disorders Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F.Hoffmann-La Roche AG, Merck and Co., Sanofi, SERVIER, Porton Biopharma, Eli Lily and Company, Novo Nordisk, Biogen, CSL Behring GmbH, Teva
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biosuperior manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Biosuperior in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Biosuperior in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Biosuperior - Market size in 2030?

Ans: The Biosuperior - Market size in 2030 will be US$ 1538 million.

Who are the main players in the Biosuperior - Market report?

Ans: The main players in the Biosuperior - Market are F.Hoffmann-La Roche AG, Merck and Co., Sanofi, SERVIER, Porton Biopharma, Eli Lily and Company, Novo Nordisk, Biogen, CSL Behring GmbH, Teva

What are the Application segmentation covered in the Biosuperior - Market report?

Ans: The Applications covered in the Biosuperior - Market report are Cancer, Diabetes, Genetic Disease, Neurological Disorders, Others

What are the Type segmentation covered in the Biosuperior - Market report?

Ans: The Types covered in the Biosuperior - Market report are G-CSF Biobetters, Insulin Biobetters, Erythropoietin Biobetters, Monoclonal Antibodies Biobetters, Others

1 Market Overview

1.1 Biosuperior Product Introduction

1.2 Global Biosuperior Market Size Forecast

1.2.1 Global Biosuperior Sales Value (2019-2030)

1.2.2 Global Biosuperior Sales Volume (2019-2030)

1.2.3 Global Biosuperior Sales Price (2019-2030)

1.3 Biosuperior Market Trends & Drivers

1.3.1 Biosuperior Industry Trends

1.3.2 Biosuperior Market Drivers & Opportunity

1.3.3 Biosuperior Market Challenges

1.3.4 Biosuperior Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Biosuperior Players Revenue Ranking (2023)

2.2 Global Biosuperior Revenue by Company (2019-2024)

2.3 Global Biosuperior Players Sales Volume Ranking (2023)

2.4 Global Biosuperior Sales Volume by Company Players (2019-2024)

2.5 Global Biosuperior Average Price by Company (2019-2024)

2.6 Key Manufacturers Biosuperior Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Biosuperior Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Biosuperior

2.9 Biosuperior Market Competitive Analysis

2.9.1 Biosuperior Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Biosuperior Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosuperior as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 G-CSF Biobetters

3.1.2 Insulin Biobetters

3.1.3 Erythropoietin Biobetters

3.1.4 Monoclonal Antibodies Biobetters

3.1.5 Others

3.2 Global Biosuperior Sales Value by Type

3.2.1 Global Biosuperior Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Biosuperior Sales Value, by Type (2019-2030)

3.2.3 Global Biosuperior Sales Value, by Type (%) (2019-2030)

3.3 Global Biosuperior Sales Volume by Type

3.3.1 Global Biosuperior Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Biosuperior Sales Volume, by Type (2019-2030)

3.3.3 Global Biosuperior Sales Volume, by Type (%) (2019-2030)

3.4 Global Biosuperior Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Cancer

4.1.2 Diabetes

4.1.3 Genetic Disease

4.1.4 Neurological Disorders

4.1.5 Others

4.2 Global Biosuperior Sales Value by Application

4.2.1 Global Biosuperior Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Biosuperior Sales Value, by Application (2019-2030)

4.2.3 Global Biosuperior Sales Value, by Application (%) (2019-2030)

4.3 Global Biosuperior Sales Volume by Application

4.3.1 Global Biosuperior Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Biosuperior Sales Volume, by Application (2019-2030)

4.3.3 Global Biosuperior Sales Volume, by Application (%) (2019-2030)

4.4 Global Biosuperior Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Biosuperior Sales Value by Region

5.1.1 Global Biosuperior Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Biosuperior Sales Value by Region (2019-2024)

5.1.3 Global Biosuperior Sales Value by Region (2025-2030)

5.1.4 Global Biosuperior Sales Value by Region (%), (2019-2030)

5.2 Global Biosuperior Sales Volume by Region

5.2.1 Global Biosuperior Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Biosuperior Sales Volume by Region (2019-2024)

5.2.3 Global Biosuperior Sales Volume by Region (2025-2030)

5.2.4 Global Biosuperior Sales Volume by Region (%), (2019-2030)

5.3 Global Biosuperior Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Biosuperior Sales Value, 2019-2030

5.4.2 North America Biosuperior Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Biosuperior Sales Value, 2019-2030

5.5.2 Europe Biosuperior Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Biosuperior Sales Value, 2019-2030

5.6.2 Asia Pacific Biosuperior Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Biosuperior Sales Value, 2019-2030

5.7.2 South America Biosuperior Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Biosuperior Sales Value, 2019-2030

5.8.2 Middle East & Africa Biosuperior Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Biosuperior Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Biosuperior Sales Value

6.2.1 Key Countries/Regions Biosuperior Sales Value, 2019-2030

6.2.2 Key Countries/Regions Biosuperior Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Biosuperior Sales Value, 2019-2030

6.3.2 United States Biosuperior Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Biosuperior Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Biosuperior Sales Value, 2019-2030

6.4.2 Europe Biosuperior Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Biosuperior Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Biosuperior Sales Value, 2019-2030

6.5.2 China Biosuperior Sales Value by Type (%), 2023 VS 2030

6.5.3 China Biosuperior Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Biosuperior Sales Value, 2019-2030

6.6.2 Japan Biosuperior Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Biosuperior Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Biosuperior Sales Value, 2019-2030

6.7.2 South Korea Biosuperior Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Biosuperior Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Biosuperior Sales Value, 2019-2030

6.8.2 Southeast Asia Biosuperior Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Biosuperior Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Biosuperior Sales Value, 2019-2030

6.9.2 India Biosuperior Sales Value by Type (%), 2023 VS 2030

6.9.3 India Biosuperior Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 F.Hoffmann-La Roche AG

7.1.1 F.Hoffmann-La Roche AG Company Information

7.1.2 F.Hoffmann-La Roche AG Introduction and Business Overview

7.1.3 F.Hoffmann-La Roche AG Biosuperior Sales, Revenue and Gross Margin (2019-2024)

7.1.4 F.Hoffmann-La Roche AG Biosuperior Product Offerings

7.1.5 F.Hoffmann-La Roche AG Recent Development

7.2 Merck and Co.

7.2.1 Merck and Co. Company Information

7.2.2 Merck and Co. Introduction and Business Overview

7.2.3 Merck and Co. Biosuperior Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Merck and Co. Biosuperior Product Offerings

7.2.5 Merck and Co. Recent Development

7.3 Sanofi

7.3.1 Sanofi Company Information

7.3.2 Sanofi Introduction and Business Overview

7.3.3 Sanofi Biosuperior Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Sanofi Biosuperior Product Offerings

7.3.5 Sanofi Recent Development

7.4 SERVIER

7.4.1 SERVIER Company Information

7.4.2 SERVIER Introduction and Business Overview

7.4.3 SERVIER Biosuperior Sales, Revenue and Gross Margin (2019-2024)

7.4.4 SERVIER Biosuperior Product Offerings

7.4.5 SERVIER Recent Development

7.5 Porton Biopharma

7.5.1 Porton Biopharma Company Information

7.5.2 Porton Biopharma Introduction and Business Overview

7.5.3 Porton Biopharma Biosuperior Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Porton Biopharma Biosuperior Product Offerings

7.5.5 Porton Biopharma Recent Development

7.6 Eli Lily and Company

7.6.1 Eli Lily and Company Company Information

7.6.2 Eli Lily and Company Introduction and Business Overview

7.6.3 Eli Lily and Company Biosuperior Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Eli Lily and Company Biosuperior Product Offerings

7.6.5 Eli Lily and Company Recent Development

7.7 Novo Nordisk

7.7.1 Novo Nordisk Company Information

7.7.2 Novo Nordisk Introduction and Business Overview

7.7.3 Novo Nordisk Biosuperior Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Novo Nordisk Biosuperior Product Offerings

7.7.5 Novo Nordisk Recent Development

7.8 Biogen

7.8.1 Biogen Company Information

7.8.2 Biogen Introduction and Business Overview

7.8.3 Biogen Biosuperior Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Biogen Biosuperior Product Offerings

7.8.5 Biogen Recent Development

7.9 CSL Behring GmbH

7.9.1 CSL Behring GmbH Company Information

7.9.2 CSL Behring GmbH Introduction and Business Overview

7.9.3 CSL Behring GmbH Biosuperior Sales, Revenue and Gross Margin (2019-2024)

7.9.4 CSL Behring GmbH Biosuperior Product Offerings

7.9.5 CSL Behring GmbH Recent Development

7.10 Teva

7.10.1 Teva Company Information

7.10.2 Teva Introduction and Business Overview

7.10.3 Teva Biosuperior Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Teva Biosuperior Product Offerings

7.10.5 Teva Recent Development

8 Industry Chain Analysis

8.1 Biosuperior Industrial Chain

8.2 Biosuperior Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Biosuperior Sales Model

8.5.2 Sales Channel

8.5.3 Biosuperior Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

F. Hoffmann-La Roche AG

List of Tables

Table 1. Biosuperior Market Trends

Table 2. Biosuperior Market Drivers & Opportunity

Table 3. Biosuperior Market Challenges

Table 4. Biosuperior Market Restraints

Table 5. Global Biosuperior Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Biosuperior Revenue Market Share by Company (2019-2024)

Table 7. Global Biosuperior Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Biosuperior Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Biosuperior Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Biosuperior Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Biosuperior Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Biosuperior

Table 13. Global Biosuperior Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosuperior as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Biosuperior Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Biosuperior Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Biosuperior Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Biosuperior Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Biosuperior Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Biosuperior Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Biosuperior Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Biosuperior Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Biosuperior Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Biosuperior Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Biosuperior Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Biosuperior Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Biosuperior Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Biosuperior Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Biosuperior Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Biosuperior Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Biosuperior Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Biosuperior Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Biosuperior Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Biosuperior Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Biosuperior Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Biosuperior Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Biosuperior Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Biosuperior Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Biosuperior Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Biosuperior Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Biosuperior Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Biosuperior Sales Value by Region (2019-2024) & (%)

Table 44. Global Biosuperior Sales Value by Region (2025-2030) & (%)

Table 45. Global Biosuperior Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Biosuperior Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Biosuperior Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Biosuperior Sales Volume by Region (2019-2024) & (%)

Table 49. Global Biosuperior Sales Volume by Region (2025-2030) & (%)

Table 50. Global Biosuperior Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Biosuperior Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Biosuperior Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Biosuperior Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Biosuperior Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Biosuperior Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Biosuperior Sales Volume, (2025-2030) & (K Units)

Table 57. F.Hoffmann-La Roche AG Company Information

Table 58. F.Hoffmann-La Roche AG Introduction and Business Overview

Table 59. F.Hoffmann-La Roche AG Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. F.Hoffmann-La Roche AG Biosuperior Product Offerings

Table 61. F.Hoffmann-La Roche AG Recent Development

Table 62. Merck and Co. Company Information

Table 63. Merck and Co. Introduction and Business Overview

Table 64. Merck and Co. Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Merck and Co. Biosuperior Product Offerings

Table 66. Merck and Co. Recent Development

Table 67. Sanofi Company Information

Table 68. Sanofi Introduction and Business Overview

Table 69. Sanofi Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Sanofi Biosuperior Product Offerings

Table 71. Sanofi Recent Development

Table 72. SERVIER Company Information

Table 73. SERVIER Introduction and Business Overview

Table 74. SERVIER Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. SERVIER Biosuperior Product Offerings

Table 76. SERVIER Recent Development

Table 77. Porton Biopharma Company Information

Table 78. Porton Biopharma Introduction and Business Overview

Table 79. Porton Biopharma Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Porton Biopharma Biosuperior Product Offerings

Table 81. Porton Biopharma Recent Development

Table 82. Eli Lily and Company Company Information

Table 83. Eli Lily and Company Introduction and Business Overview

Table 84. Eli Lily and Company Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Eli Lily and Company Biosuperior Product Offerings

Table 86. Eli Lily and Company Recent Development

Table 87. Novo Nordisk Company Information

Table 88. Novo Nordisk Introduction and Business Overview

Table 89. Novo Nordisk Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Novo Nordisk Biosuperior Product Offerings

Table 91. Novo Nordisk Recent Development

Table 92. Biogen Company Information

Table 93. Biogen Introduction and Business Overview

Table 94. Biogen Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Biogen Biosuperior Product Offerings

Table 96. Biogen Recent Development

Table 97. CSL Behring GmbH Company Information

Table 98. CSL Behring GmbH Introduction and Business Overview

Table 99. CSL Behring GmbH Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. CSL Behring GmbH Biosuperior Product Offerings

Table 101. CSL Behring GmbH Recent Development

Table 102. Teva Company Information

Table 103. Teva Introduction and Business Overview

Table 104. Teva Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Teva Biosuperior Product Offerings

Table 106. Teva Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Biosuperior Downstream Customers

Table 110. Biosuperior Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Biosuperior Product Picture

Figure 2. Global Biosuperior Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Biosuperior Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Biosuperior Sales Volume (2019-2030) & (K Units)

Figure 5. Global Biosuperior Sales Price (2019-2030) & (US$/Unit)

Figure 6. Biosuperior Report Years Considered

Figure 7. Global Biosuperior Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Biosuperior Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Biosuperior Revenue in 2023

Figure 10. Biosuperior Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. G-CSF Biobetters Picture

Figure 12. Insulin Biobetters Picture

Figure 13. Erythropoietin Biobetters Picture

Figure 14. Monoclonal Antibodies Biobetters Picture

Figure 15. Others Picture

Figure 16. Global Biosuperior Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Biosuperior Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Biosuperior Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 19. Global Biosuperior Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Biosuperior Price by Type (2019-2030) & (US$/Unit)

Figure 21. Product Picture of Cancer

Figure 22. Product Picture of Diabetes

Figure 23. Product Picture of Genetic Disease

Figure 24. Product Picture of Neurological Disorders

Figure 25. Product Picture of Others

Figure 26. Global Biosuperior Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 27. Global Biosuperior Sales Value Market Share by Application, 2023 & 2030

Figure 28. Global Biosuperior Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 29. Global Biosuperior Sales Volume Market Share by Application, 2023 & 2030

Figure 30. Global Biosuperior Price by Application (2019-2030) & (US$/Unit)

Figure 31. North America Biosuperior Sales Value (2019-2030) & (US$ Million)

Figure 32. North America Biosuperior Sales Value by Country (%), 2023 VS 2030

Figure 33. Europe Biosuperior Sales Value (2019-2030) & (US$ Million)

Figure 34. Europe Biosuperior Sales Value by Country (%), 2023 VS 2030

Figure 35. Asia Pacific Biosuperior Sales Value (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Biosuperior Sales Value by Country (%), 2023 VS 2030

Figure 37. South America Biosuperior Sales Value (2019-2030) & (US$ Million)

Figure 38. South America Biosuperior Sales Value by Country (%), 2023 VS 2030

Figure 39. Middle East & Africa Biosuperior Sales Value (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Biosuperior Sales Value by Country (%), 2023 VS 2030

Figure 41. Key Countries/Regions Biosuperior Sales Value (%), (2019-2030)

Figure 42. Key Countries/Regions Biosuperior Sales Volume (%), (2019-2030)

Figure 43. United States Biosuperior Sales Value, (2019-2030) & (US$ Million)

Figure 44. United States Biosuperior Sales Value by Type (%), 2023 VS 2030

Figure 45. United States Biosuperior Sales Value by Application (%), 2023 VS 2030

Figure 46. Europe Biosuperior Sales Value, (2019-2030) & (US$ Million)

Figure 47. Europe Biosuperior Sales Value by Type (%), 2023 VS 2030

Figure 48. Europe Biosuperior Sales Value by Application (%), 2023 VS 2030

Figure 49. China Biosuperior Sales Value, (2019-2030) & (US$ Million)

Figure 50. China Biosuperior Sales Value by Type (%), 2023 VS 2030

Figure 51. China Biosuperior Sales Value by Application (%), 2023 VS 2030

Figure 52. Japan Biosuperior Sales Value, (2019-2030) & (US$ Million)

Figure 53. Japan Biosuperior Sales Value by Type (%), 2023 VS 2030

Figure 54. Japan Biosuperior Sales Value by Application (%), 2023 VS 2030

Figure 55. South Korea Biosuperior Sales Value, (2019-2030) & (US$ Million)

Figure 56. South Korea Biosuperior Sales Value by Type (%), 2023 VS 2030

Figure 57. South Korea Biosuperior Sales Value by Application (%), 2023 VS 2030

Figure 58. Southeast Asia Biosuperior Sales Value, (2019-2030) & (US$ Million)

Figure 59. Southeast Asia Biosuperior Sales Value by Type (%), 2023 VS 2030

Figure 60. Southeast Asia Biosuperior Sales Value by Application (%), 2023 VS 2030

Figure 61. India Biosuperior Sales Value, (2019-2030) & (US$ Million)

Figure 62. India Biosuperior Sales Value by Type (%), 2023 VS 2030

Figure 63. India Biosuperior Sales Value by Application (%), 2023 VS 2030

Figure 64. Biosuperior Industrial Chain

Figure 65. Biosuperior Manufacturing Cost Structure

Figure 66. Channels of Distribution (Direct Sales, and Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-38B2538

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Rheumatoid Arthritis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5A13262

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Psoriasis Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28R2574

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Rubber Stopper Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-15W7068

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Biosuperior - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-22D13086

Biosuperior - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Biosuperior - Market Size

Biosuperior - Market

Report Scope

Scope of Biosuperior - Market Report

Chapter Outline

FAQ for this report

What is the Biosuperior - Market size in 2030?

Who are the main players in the Biosuperior - Market report?

What are the Application segmentation covered in the Biosuperior - Market report?

What are the Type segmentation covered in the Biosuperior - Market report?

FEATURED COMPANIES

RELATED REPORTS